Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$17.63
-0.27-1.51%
Last update: May 15, 3:08 PM
OrthoPediatrics Corp Analyst Ratings
KIDSNASDAQ
OrthoPediatrics Analyst Ratings and Price Targets | NASDAQ:KIDS | Benzinga
OrthoPediatrics Corp has a consensus price target of $28.17 based on the ratings of 12 analysts. The high is $50 issued by Citizens Capital Markets on March 21, 2025. The low is $20 issued by Truist Securities on March 2, 2026. The 3 most-recent analyst ratings were released by BTIG, Truist Securities, and Needham on May 1, 2026, March 2, 2026, and February 27, 2026, respectively. With an average price target of $24.67 between BTIG, Truist Securities, and Needham, there's an implied 39.91% upside for OrthoPediatrics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BTIG
Truist Securities
Needham
TD Cowen
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for OrthoPediatrics
Loading calendar...
FAQ
What is the target price for OrthoPediatrics (KIDS) stock?
The latest price target for OrthoPediatrics (NASDAQ:KIDS) was reported by BTIG on May 1, 2026. The analyst firm set a price target for $24.00 expecting KIDS to rise to within 12 months (a possible 36.13% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OrthoPediatrics (KIDS)?
The latest analyst rating for OrthoPediatrics (NASDAQ:KIDS) was provided by BTIG, and OrthoPediatrics reiterated their buy rating.
When was the last upgrade for OrthoPediatrics (KIDS)?
There is no last upgrade for OrthoPediatrics
When was the last downgrade for OrthoPediatrics (KIDS)?
The last downgrade for OrthoPediatrics Corp happened on January 25, 2024 when Truist Securities changed their price target from $39 to $31 for OrthoPediatrics Corp.
When is the next analyst rating going to be posted or updated for OrthoPediatrics (KIDS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OrthoPediatrics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OrthoPediatrics was filed on May 1, 2026 so you should expect the next rating to be made available sometime around May 1, 2027.
Is the Analyst Rating OrthoPediatrics (KIDS) correct?
While ratings are subjective and will change, the latest OrthoPediatrics (KIDS) rating was a reiterated with a price target of $24.00 to $24.00. The current price OrthoPediatrics (KIDS) is trading at is $17.63, which is out of the analyst’s predicted range.
